NCT02002858 2013.

Study name	Integrated smoking cessation treatment for emotional dysregulation
Methods	A 2‐arm, parallel‐group, randomised controlled trial comparing 2 group treatment approaches: (1): an educational‐supportive psychotherapy and standard smoking cessation treatment; and (2) an integrated smoking cessation and anxiety and depression management treatment programme (SDAT). Blinding/masking: single‐blind (outcome‐assessors will be blinded to group allocation)
Participants	Psychiatric population: aged 18 ‐ 65 years with elevated anxiety or depression who smoke an average of at least 6 cigarettes per day and report being motivated to quit smoking
Interventions	Comparing 2 group treatment approaches: A) cognitive behavioural treatment program which blends smoking cessation, anxiety and depression management/reduction treatment strategies (SDAT), with nicotine patch B) educational‐based psychotherapy and standard smoking cessation treatment programme (active comparator) with nicotine patch
Outcomes	Primary outcome: smoking status using the Timeline Follow‐Back Assessment (Time Frame: Change from baseline at 2, 4, 8, 10, 16, and 24 weeks post quit day)
Starting date	October 2014 (completed May 2017)
Contact information	Michael J Zvolensky, Ph.D. Anxiety and Health Research Laboratory and Substance Use Treatment Clinic, University of Houston Houston, Texas, United States, 77205
Notes	Registry ID: NCT02002858. Smoking Cessation for Depression and Anxiety Treatment. 2013 Funding source: University of Houston, National Institute on Drug Abuse (NIDA) Declaration of interests: none specified